A randomized controlled study for evaluation of psyllium effects on kinetics of carbohydrate absorption

Journal of Research in Medical Sciences

Volumn 12, Issue 3, 2007, Pages 125-130

  Dastjerdi, Mansour Siavash ^a   Salehioun, Maryam ^b   Najafian, Alireza ^b   Amini, Masoud ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Postprandial hyperglycemia; Psyllium; Type 2 diabetes mellitus

Indexed keywords

ACARBOSE; GLUCOSE; ISPAGULA; MEGLITINIDE;

ADULT; ARTICLE; CARBOHYDRATE ABSORPTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MEAL; MILK; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL;

EID: 51849084436     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Gerich JE. Postprandial hyperglycemia and cardiovascular disease. Endocr Pract 2006; 12 Suppl 1:47-51.
2. Yamagishi S, Nakamura K, Matsui T, Takenaka K, Jinnouchi Y, Imaizumi T. Cardiovascular disease in diabetes. Mini Rev Med Chem 2006; 6(3):313-318.
3. Home P. Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin 2005; 21(7):989-998.
4. Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR et al. Postprandial glucose regulation: New data and new implications. Clin Ther 2005; 27 Suppl 2:S42-S56.
5. Brindisi MC, Rabasa-Lhoret R, Chiasson JL. Postprandial hyperglycaemia: to treat or not to treat? Diabetes Metab 2006; 32(2):105-111.
6. Ceriello A, Hanefeld M, Leiter L, Monnier L, Moses A, Owens D et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004; 164(19):2090-2095.
7. Hanefeld M, Temelkova-Kurktschiev T. Control of post-prandial hyperglycemia-an essential part of good diabetes treatment and prevention of cardiovascular complications. Nutr Metab Cardiovasc Dis 2002; 12(2):98-107.
8. Yamada K. [Pharmacological treatment of postprandial hyperglycemia in hypertensive patients with type 2 diabetes mellitus]. Nippon Rinsho 2003; 61(7):1219-1223.
9. Brand-Miller JC. Glycemic index in relation to coronary disease. Asia Pac J Clin Nutr 2004; 13(Suppl):S3.
10. Frati Munari AC, Benitez PW, Raul Ariza AC, Casarrubias M. Lowering glycemic index of food by acarbose and Plantago psyllium mucilage. Arch Med Res 1998; 29(2):137-141.
11. Hanefeld M, Temelkova-Kurktschiev T. Control of post-prandial hyperglycemia - an essential part of good diabetes treatment and prevention of cardiovascular complications. Nutr Metab Cardiovasc Dis 2002; 12(2):98-107.
12. Karasik A. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum. Ann Med 2005; 37(4):250-258.
13. Zeymer U. Cardiovascular benefits of acarbose in impaired glucose tolerance and type 2 diabetes. Int J Cardiol 2006; 107(1):11-20.
14. Katahira H, Ishida H. [Indication and side effect of alpha glucosidase inhibitor]. Nippon Rinsho 2002; 60 Suppl 9:399-408.
15. Perusicova J. [Pitfalls in treatment with oral antidiabetic agents]. Vnitr Lek 1998; 44(1):30-35.
16. Yee HS, Fong NT. A review of the safety and efficacy of acarbose in diabetes mellitus. Pharmacotherapy 1996; 16(5):792-805.
17. Trepel F. [Dietary fibre: more than a matter of dietetics. II. Preventative and therapeutic uses]. Wien Klin Wochenschr 2004; 116(15-16):511-522.
18. Vuksan V, Korsic M, Posavi-Antonovic A. [Metabolic diseases and the high-fiber diet]. Lijec Vjesn 1997; 119(3-4): 125-127.
19. Anderson JW, Allgood LD, Turner J, Oeltgen PR, Daggy BP. Effects of psyllium on glucose and serum lipid responses in men with type 2 diabetes and hypercholesterolemia. Am J Clin Nutr 1999; 70(4):466-473.
20. Moreno LA, Tresaco B, Bueno G, Fleta J, Rodriguez G, Garagorri JM et al. Psyllium fibre and the metabolic control of obese children and adolescents. J Physiol Biochem 2003; 59(3):235-242.
21. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr 2002; 56(9):830-842.
22. Nuttall FQ. Dietary fiber in the management of diabetes. Diabetes 1993; 42(4):503-508.
23. Ziai SA, Larijani B, Akhoondzadeh S, Fakhrzadeh H, Dastpak A, Bandarian F et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol 2005; 102(2):202-207.
24. Fugh-Berman A. Herb-drug interactions. Lancet 2000; 355(9198):134-138.
25. Nordstrom M, Melander A, Robertsson E, Steen B. Influence of wheat bran and of a bulk-forming ispaghula cathartic on the bioavailability of digoxin in geriatric in-patients. Drug Nutr Interact 1987; 5(2):67-69.
26. Perlman BB. Interaction between lithium salts and ispaghula husk. Lancet 1990; 335(8686):416.
27. Toutoungi M, Schulz P, Widmer J, Tissot R. [Probable interaction of psyllium and lithium]. Therapie 1990; 45(4):358-360.
28. Pastors JG, Blaisdell PW, Balm TK, Asplin CM, Pohl SL. Psyllium fiber reduces rise in postprandial glucose and insulin concentrations in patients with non-insulin-dependent diabetes. Am J Clin Nutr 1991; 53(6):1431-1435.
29. Blickle JF. Meglitinide analogues: a review of clinical data focused on recent trials. Diabetes Metab 2006; 32(2):113-120.
30. Li JW, Tian HM, Yu HL, Zhang XX, Zhao GZ, Wang JN. [Comparison of efficacy between nateglinide and repaglinide in treating type 2 diabetes: a randomized controlled double-blind clinical trial]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005; 36(2):267-270.
31. Rosenstock J, Hassman DR, Madder RD, Brazinsky SA, Farrell J, Khutoryansky N et al. Repaglinide versus nateglinide monotherapy: a randomized, multicenter study. Diabetes Care 2004; 27(6):1265-1270.
32. Plosker GL, Figgitt DP. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Pharmacoeconomics 2004; 22(6):389-411.
33. Rizzo MR, Barbieri M, Grella R, Passariello N, Barone M, Paolisso G. Repaglinide is more efficient than glimepiride on insulin secretion and post-prandial glucose excursions in patients with type 2 diabetes. A short term study. Diabetes Metab 2004; 30(1):81-89.
34. McLeod JF. Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent. Clin Pharmacokinet 2004; 43(2):97-120.
35. Wolever TM, Vuksan V, Eshuis H, Spadafora P, Peterson RD, Chao ES et al. Effect of method of administration of psyllium on glycemic response and carbohydrate digestibility. J Am Coll Nutr 1991; 10(4):364-371.
36. Rodriguez-Moran M, Guerrero-Romero F, Lazcano-Burciaga G. Lipid- and glucose-lowering efficacy of Plantago Psyllium in type II diabetes. J Diabetes Complications 1998; 12(5):273-278.